Jianzhi Wu

652 total citations
25 papers, 483 citations indexed

About

Jianzhi Wu is a scholar working on Epidemiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jianzhi Wu has authored 25 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 11 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jianzhi Wu's work include Liver Disease Diagnosis and Treatment (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Liver physiology and pathology (4 papers). Jianzhi Wu is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Liver physiology and pathology (4 papers). Jianzhi Wu collaborates with scholars based in China. Jianzhi Wu's co-authors include Xiaojiaoyang Li, Runping Liu, Fei Zhou, Guangrui Huang, Guifang Fan, Yajing Li, Yajing Li, Yajie Cai, Yajing Li and Yijie Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and Journal of Ethnopharmacology.

In The Last Decade

Jianzhi Wu

22 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianzhi Wu China 15 200 195 90 85 52 25 483
Guangdong Tong China 14 164 0.8× 219 1.1× 85 0.9× 85 1.0× 28 0.5× 48 463
Yihan Qian China 12 167 0.8× 195 1.0× 84 0.9× 81 1.0× 48 0.9× 25 469
Mengjuan Wei China 12 146 0.7× 227 1.2× 147 1.6× 70 0.8× 32 0.6× 25 522
Yue‐Rong Ma China 9 124 0.6× 159 0.8× 111 1.2× 114 1.3× 34 0.7× 15 476
Xinyan Xue China 15 124 0.6× 193 1.0× 103 1.1× 72 0.8× 66 1.3× 28 548
Quan Jin China 19 159 0.8× 366 1.9× 106 1.2× 73 0.9× 66 1.3× 33 694
Yajie Cai China 12 112 0.6× 194 1.0× 82 0.9× 44 0.5× 58 1.1× 29 439
Amro El‐Karef Egypt 16 174 0.9× 236 1.2× 164 1.8× 152 1.8× 38 0.7× 24 681
Musen Lin China 11 127 0.6× 298 1.5× 90 1.0× 56 0.7× 32 0.6× 17 512
Jiong Jiang China 10 117 0.6× 174 0.9× 61 0.7× 44 0.5× 67 1.3× 24 483

Countries citing papers authored by Jianzhi Wu

Since Specialization
Citations

This map shows the geographic impact of Jianzhi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianzhi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianzhi Wu more than expected).

Fields of papers citing papers by Jianzhi Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianzhi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianzhi Wu. The network helps show where Jianzhi Wu may publish in the future.

Co-authorship network of co-authors of Jianzhi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianzhi Wu. A scholar is included among the top collaborators of Jianzhi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianzhi Wu. Jianzhi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Fanghong, et al.. (2025). Acteoside ameliorates hepatocyte ferroptosis and hepatic ischemia-reperfusion injury via targeting PCBP2. Acta Pharmaceutica Sinica B. 15(4). 2077–2094. 6 indexed citations
2.
Zheng, Qi, Xiaojiaoyang Li, Fanghong Li, et al.. (2025). Temporal-spatially metabolic reprogramming rewires the landscape of H3K27 acetylation to enable the initiation of liver regeneration. Science Bulletin. 70(17). 2743–2747.
3.
4.
Ma, Zhi, J Li, Yang Yang, et al.. (2024). Si-Wu-Tang attenuates hepatocyte PANoptosis and M1 polarization of macrophages in non-alcoholic fatty liver disease by influencing the intercellular transfer of mtDNA. Journal of Ethnopharmacology. 328. 118057–118057. 16 indexed citations
5.
Wu, Jianzhi, Zhi Ma, Rong Sun, et al.. (2024). Precise subcellular organelle-targeted analyses of the hepatotoxicity of rhubarb. 4(2). 243–256. 5 indexed citations
6.
Wu, Jianzhi, Yijie Li, Tiegang Liu, et al.. (2024). SGK1 aggravates idiopathic pulmonary fibrosis by triggering H3k27ac-mediated macrophage reprogramming and disturbing immune homeostasis. International Journal of Biological Sciences. 20(3). 968–986. 10 indexed citations
7.
Wu, Jianzhi, et al.. (2024). Tao-Hong-Si-Wu-Tang improves thioacetamide-induced liver fibrosis by reversing ACSL4-mediated lipid accumulation and promoting mitophagy. Journal of Ethnopharmacology. 333. 118456–118456. 6 indexed citations
8.
Liu, Runping, Yajing Li, Jianzhi Wu, et al.. (2023). Acteoside ameliorates hepatic ischemia-reperfusion injury via reversing the senescent fate of liver sinusoidal endothelial cells and restoring compromised sinusoidal networks. International Journal of Biological Sciences. 19(15). 4967–4988. 18 indexed citations
9.
Li, Xiaojiaoyang, Fei Zhou, Yajing Li, et al.. (2023). LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles. Acta Pharmacologica Sinica. 44(12). 2479–2491. 21 indexed citations
10.
Li, Yijie, Jianzhi Wu, Tiegang Liu, et al.. (2023). Salvianolic acid B protects against pulmonary fibrosis by attenuating stimulating protein 1‐mediated macrophage and alveolar type 2 cell senescence. Phytotherapy Research. 38(2). 620–635. 14 indexed citations
11.
Li, Yijie, Runping Liu, Fei Zhou, et al.. (2023). Aurantio-obtusin ameliorates obesity by activating PPARα-dependent mitochondrial thermogenesis in brown adipose tissues. Acta Pharmacologica Sinica. 44(9). 1826–1840. 12 indexed citations
12.
Zhou, Fei, Guifang Fan, Chuanyang Liu, et al.. (2022). Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways. Frontiers in Pharmacology. 12. 826628–826628. 35 indexed citations
13.
Wu, Jianzhi, Yijie Li, Jia Liu, et al.. (2022). A novel pulmonary fibrosis murine model with immune‐related liver injury. SHILAP Revista de lepidopterología. 6(3). 274–282. 6 indexed citations
14.
Li, Yajing, Runping Liu, Qi Zheng, et al.. (2022). Tetramethylpyrazine prevents liver fibrotic injury in mice by targeting hepatocyte-derived and mitochondrial DNA-enriched extracellular vesicles. Acta Pharmacologica Sinica. 43(8). 2026–2041. 40 indexed citations
15.
Wu, Jianzhi, Yajing Li, Guangrui Huang, et al.. (2021). Mechanisms exploration of Angelicae Sinensis Radix and Ligusticum Chuanxiong Rhizoma herb-pair for liver fibrosis prevention based on network pharmacology and experimental pharmacologylogy. Chinese Journal of Natural Medicines. 19(4). 241–254. 30 indexed citations
16.
Wu, Jianzhi, Feng Gao, Fei Zhou, et al.. (2021). Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis. Chinese Medicine. 16(1). 112–112. 25 indexed citations
17.
Wu, Jianzhi, Guifang Fan, Fei Zhou, et al.. (2021). Ferulic Acid Ameliorates Hepatic Inflammation and Fibrotic Liver Injury by Inhibiting PTP1B Activity and Subsequent Promoting AMPK Phosphorylation. Frontiers in Pharmacology. 12. 754976–754976. 47 indexed citations
18.
Cai, Yajie, Bing Xu, Fei Zhou, et al.. (2021). Si-Ni-San ameliorates chronic colitis by modulating type I interferons-mediated inflammation. Phytomedicine. 84. 153495–153495. 31 indexed citations
19.
Wu, Jianzhi, Guangrui Huang, Yajing Li, & Xiaojiaoyang Li. (2020). Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases. Chinese Medicine. 15(1). 89–89. 50 indexed citations
20.
Li, Yajing, Runping Liu, Jianzhi Wu, & Xiaojiaoyang Li. (2020). Self-eating: friend or foe? The emerging role of autophagy in fibrotic diseases. Theranostics. 10(18). 7993–8017. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guangdong Tong Breakdown of academic impact, for papers by Yihan Qian Breakdown of academic impact, for papers by Mengjuan Wei Breakdown of academic impact, for papers by Yue‐Rong Ma Breakdown of academic impact, for papers by Xinyan Xue Breakdown of academic impact, for papers by Quan Jin Breakdown of academic impact, for papers by Yajie Cai Breakdown of academic impact, for papers by Amro El‐Karef Breakdown of academic impact, for papers by Musen Lin Breakdown of academic impact, for papers by Jiong Jiang
Rankless by CCL
2026